Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant is a research paper published in Pharmaceutics (2020). On theSindex it has a DataRank of 0. It has been cited 105 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: R01AI120749
National Institute of General Medical Sciences
Grant: R01GM127558
Consejo Nacional de Ciencia y Tecnología
Grant: Fellowship
Gilead Sciences
Grant: SRA
NIAID NIH HHS
Grant: P30 AI094189
National Institutes of Health
Grant: 5R01GM127558-02
A nanofluidic platform for tunable drug delivery
National Institutes of Health
Grant: 5R01AI120749-03
A novel nanochannel system for sustained delivery of Tenofovir Alafenamide Fumarate and Emtricitabine for HIV pre-exposure prophylaxis
Fields of Study
Keywords
Sustainable Development Goals